Contact
searchSearch
HMP Global

The Dermatologist

Featured

Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
Raj Chovatiya, MD, PhD
Conference Coverage
Individualizing Biologic Therapy for Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026...
10/09/2026
The Dermatologist
Lisa Swanson
Conference Coverage
Expert Insights: Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical...
10/09/2026
The Dermatologist
FDA Alerts
FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism in Adults
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
News
Pediatric Psoriasis Review Highlights Diagnostic Challenges, Expanding Role of Biologics
10/07/2026
Jessica Garlewicz
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can...
10/07/2026
The Dermatologist
News
Psoriasis Reframed as Systemic Disease With Metabolic and Hepatic Implications
10/07/2026
Jessica Garlewicz
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized...
10/07/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
News
Microbial Dysbiosis May Shape Psoriasis Pathogenesis Through the Gut-Skin Axis
10/07/2026
Jessica Garlewicz
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial...
10/07/2026
The Dermatologist

From The Issue

Derm Dx
What Caused This Hyperpigmentation?
10/02/2026
Lanah Almatroud, BA; Rania Djemil, BS; Amor Khachemoune, MD, FAAD, FACMS
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran,...
10/02/2026
The Dermatologist
Clinical Tips
Handling Unrealistic Cosmetic Expectations
10/02/2026
Benjamin Barankin, MD, FRCPC; Ronald Vender, MD, FRCPC; Susan Poelman, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
10/02/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
The Eye-Skin Connection: Ocular Red Flags Every Dermatologist Should Know
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Derm Dx
What Is the Cause of This Color Change on the Neck?
09/03/2026
Sümeyye Aktaş, MD; Mehmet Ali Demirci, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented...
09/03/2026
The Dermatologist
Clinical Tips
The “Ear Clue” for Seborrheic Dermatitis
09/03/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
09/03/2026
The Dermatologist
Feature Story
Special Delivery of Topical Interest: Understanding Vehicle Formulation for Nonsteroidal Prescription Eczema Creams
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Derm Dx
What Are These Pigmented, Pedunculated Lesions?
08/04/2026
Tanya Henry, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American...
08/04/2026
The Dermatologist
Clinical Tips
Engaging Your Patients and Your Team
08/04/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
08/04/2026
The Dermatologist

Multimedia

Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasized individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist
Doris Day
Videos
Facial Fillers: Holistic Rejuvenation, Facial Balancing, and Natural Results
09/28/2026
Doris Day, MD; Riya Gandhi, MA
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why...
09/28/2026
The Dermatologist
Helen He
Videos
Inflammaging and Cellular Senescence: Emerging Strategies for Skin Longevity
09/28/2026
Helen He, MD; Riya Gandhi, MA
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how...
09/28/2026
The Dermatologist
Helen He
Videos
The Science of Skin Aging: Cellular Mechanisms and Targeted Longevity Strategies
09/28/2026
Dr Helen He explores the molecular drivers of skin aging, including cellular senescence, chronic inflammation, oxidative stress, skin barrier dysfunction, and impaired DNA repair.
Dr Helen He explores the molecular drivers of skin aging, including cellular senescence, chronic inflammation, oxidative stress, skin barrier dysfunction, and impaired DNA repair.
Dr Helen He explores the...
09/28/2026
The Dermatologist
Feser
Videos
Chronic Spontaneous Urticaria: New Insights Into Mast Cells and Targeted Therapies
09/28/2026
Christina Feser, DO; Riya Gandhi, MA
Dr Christina Feser discusses evolving insights into the pathophysiology of chronic spontaneous urticaria (CSU), including the central role of mast cell activation and the shift beyond antihistamine-focused treatment.
Dr Christina Feser discusses evolving insights into the pathophysiology of chronic spontaneous urticaria (CSU), including the central role of mast cell activation and the shift beyond antihistamine-focused treatment.
Dr Christina Feser discusses...
09/28/2026
The Dermatologist
Raj Chovatiya
Videos
Chronic Spontaneous Urticaria: Type 2 Inflammation and Mast Cell Hyperreactivity
09/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how...
09/01/2026
The Dermatologist

Partner Reviewed

NRS Approved Features
Perimenopause May Mark Rosacea’s Onset or Worsening
10/02/2026
Eden Robins
Hormonal fluctuations, hot flashes, and skin barrier changes during this stage of life may trigger rosacea onset or worsen existing symptoms.
Hormonal fluctuations, hot flashes, and skin barrier changes during this stage of life may trigger rosacea onset or worsen existing symptoms.
Hormonal fluctuations, hot...
10/02/2026
The Dermatologist
NEA Approved Features
The State of AD: Why We Are Building the First Indicator Report of Its Kind
10/02/2026
Coleen Stern, MA
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the...
10/02/2026
The Dermatologist
NRS Approved Features
Gabapentin May Help Patients With Neurogenic Rosacea
08/04/2026
Andrew Huff
This disease subtype is often difficult to treat, with patients reporting minimal or no improvement in signs and symptoms with standard therapies.
This disease subtype is often difficult to treat, with patients reporting minimal or no improvement in signs and symptoms with standard therapies.
This disease subtype is often...
08/04/2026
The Dermatologist
NEA Approved Features
Closing Gaps in Eczema Research
06/08/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
06/08/2026
The Dermatologist
NRS Approved Features
Artificial Intelligence for Rosacea Diagnosis Shows Both Promise and Shortcomings
04/06/2026
Eden Robins
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the...
04/06/2026
The Dermatologist
NEA Approved Features
Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NRS Approved Features
Do Fungi Play a Role in Rosacea?
01/30/2026
Andrew Huff
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may...
01/30/2026
The Dermatologist
NPF Endorsed Features
Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors
01/30/2026
Lisa Kuhns, PhD, MD
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical...
01/30/2026
The Dermatologist
NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist

News and FDA Alerts

cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
FDA Alerts
FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism in Adults
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
News
Pediatric Psoriasis Review Highlights Diagnostic Challenges, Expanding Role of Biologics
10/07/2026
Jessica Garlewicz
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can...
10/07/2026
The Dermatologist
News
Psoriasis Reframed as Systemic Disease With Metabolic and Hepatic Implications
10/07/2026
Jessica Garlewicz
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized...
10/07/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
News
Microbial Dysbiosis May Shape Psoriasis Pathogenesis Through the Gut-Skin Axis
10/07/2026
Jessica Garlewicz
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
Alopecia
FDA Alerts
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
News
Poor Cardiovascular-Kidney-Metabolic Health Linked to Psoriasis Risk, Reduced Life Expectancy
09/03/2026
Jessica Garlewicz
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor...
09/03/2026
The Dermatologist

Quizzes and Polls

Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist

Professional Development

Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 4, Combatting Barriers to Care For Elder Patients
10/16/2024
Adam Friedman, MD
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024
Adam Friedman, MD; Jaya Manjunath
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
Aging and Geriatric Evaluation in Dermatology
Podcasts
The ElderDerm: Episode 2, Aging and Geriatric Evaluation in Dermatology
04/22/2024
Adam Friedman, MD; Jaya Manjunath
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
ElderDerm
Podcasts
The ElderDerm: Episode 1, Geriatric Dermatology
01/29/2024
Jaya Manjunath; Adam Friedman, MD
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm...
01/29/2024
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 4, Residency Insights
09/26/2023
Adam Friedman, MD; Adam Rosenfeld; Alexis Carrington
"The Real Derm: Residency Unplugged" is a podcast looking at advanced dermatology residency and clinical insights. 
"The Real Derm: Residency Unplugged" is a podcast looking at advanced dermatology residency and clinical insights. 
"The Real Derm: Residency...
09/26/2023
The Dermatologist
Conference Preview
Conference Preview: Dermatology Week Fall 2023
08/16/2023
Riya Gandhi, MA
Experience the cutting-edge world of dermatology at the much-anticipated Dermatology Week 2023!
Experience the cutting-edge world of dermatology at the much-anticipated Dermatology Week 2023!
Experience the cutting-edge...
08/16/2023
The Dermatologist
Real Derm: Dr Adam Friedman
Podcasts
The Real Derm: Episode 3, Maneuvering Conferences
05/11/2022
Adam Friedman, MD
In this episode, Dr Adam Friedman interviews "The Real Derm" podcast stars, Dr Kamaria Nelson and Dr Emily Murphy on attending conferences.
In this episode, Dr Adam Friedman interviews "The Real Derm" podcast stars, Dr Kamaria Nelson and Dr Emily Murphy on attending conferences.
In this episode, Dr Adam...
05/11/2022
The Dermatologist
atopic dermatitis (AD) Rash
Conference Coverage
Exploring the Impact of Itch on Patients and Caregivers
04/19/2022
Riya Gandhi, MA
Wendy Smith-Begolka, MD, kicked off her session at the 4th Annual Revolutionizing Atopic Dermatitis Conference.
Wendy Smith-Begolka, MD, kicked off her session at the 4th Annual Revolutionizing Atopic Dermatitis Conference.
Wendy Smith-Begolka, MD, kicked...
04/19/2022
The Dermatologist
atopic dermatitis rash
Conference Insider
Recap of the 4th Annual Revolutionizing Atopic Dermatitis Conference
04/13/2022
Jessica Garlewicz
The 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference took place virtually and in-person on April 9–11, 2022, in Baltimore, MD.
The 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference took place virtually and in-person on April 9–11, 2022, in Baltimore, MD.
The 4th Annual Revolutionizing...
04/13/2022
The Dermatologist

Conference Coverage

Raj Chovatiya, MD, PhD
Conference Coverage
Individualizing Biologic Therapy for Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026...
10/09/2026
The Dermatologist
Lisa Swanson
Conference Coverage
Expert Insights: Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/09/2026
Jessica Garlewicz
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical...
10/09/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
thor
Videos
BMI, Biological Aging, and Skin Longevity: Beyond Weight in Dermatology
06/04/2026
Dominik Thor, PhD, MSc; Riya Gandhi, MA
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how obesity, metabolic health, and biological aging intersect to influence skin health and longevity.
Dominik Thor discusses how...
06/04/2026
The Dermatologist
ablon
Videos
GLP-1 Dermatologic Side Effects: Facial Volume Loss, Hair Loss, and Skin Changes
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the most common dermatologic effects associated with GLP-1 receptor agonists, including facial volume loss, skin laxity, telogen effluvium, hypersensitivity reactions, and delayed wound healing.
Dr Glynis Ablon discusses the...
06/04/2026
The Dermatologist
kelly
Videos
Port Wine Capillary Malformations: Laser Treatment and Emerging Options
06/04/2026
Kristen Kelly, MD; Riya Gandhi, MA
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches.
Dr Kristen Kelly discusses...
06/04/2026
The Dermatologist
thor
Videos
Longevity Medicine in Dermatology: Prevention, Diagnostics, and Evidence-Based Innovation
06/04/2026
Dominik Thor, PhD, MSc; Riya Gandhi, MA
Dominik Thor discusses how longevity medicine may shape the future of dermatology by shifting care from reactive treatment to preventive, healthspan-focused strategies.
Dominik Thor discusses how longevity medicine may shape the future of dermatology by shifting care from reactive treatment to preventive, healthspan-focused strategies.
Dominik Thor discusses how...
06/04/2026
The Dermatologist
ablon
Videos
Hair Loss Supplements: Evidence-Based Nutraceuticals and Integrative Hair Restoration
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatologists can evaluate hair loss supplements using clinical evidence, safety standards, and manufacturing quality rather than marketing claims alone.
Dr Glynis Ablon discusses how dermatologists can evaluate hair loss supplements using clinical evidence, safety standards, and manufacturing quality rather than marketing claims alone.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist
Lain
Videos
Rosacea and Gut Health: Exploring the Gut-Skin Connection
05/27/2026
Ted Lain, MD; Riya Gandhi, MA
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the...
05/27/2026
The Dermatologist

Popular Articles

Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 4, Combatting Barriers to Care For Elder Patients
10/16/2024
Adam Friedman, MD
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
Jessica Garlewicz
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use